Skip to main content

Part of Cancer staging guidance sheets

Retinoblastoma (ICD10 C69.2)

Current Chapter

Current chapter – Retinoblastoma (ICD10 C69.2)


Introduction

This is the data sheet for TNM 9th edition staging of retinoblastoma (ICD10 C69.2).

For more detailed information regarding TNM staging, please see pages 217-220 of the UICC TNM 9 book.


Stage groupings

Clinical Stage

Stage Group

T stage

N stage

M stage

Stage I

T1, T2, T3

N0

M0

Stage II

T4a

N0

M0

Stage III

T4b

N0

M0

Any T

N1

M0

Stage IV

Any T

Any N

M1

Pathological Stage

Stage I

T1, T2, T3

N0

M0

Stage II

T4

N0

M0

Stage III

Any T

N1

M0

Stage IV

Any T

Any N

M1


TNM clinical classification

T - primary tumour

T value

Description

cTX

Primary tumour cannot be assessed.

cT0

No evidence of primary tumour.

cT1

Tumour confined to the retina with subretinal fluid no more than 5 mm from the base of any tumour, without retinal detachment

cT1a - No tumour in either eye is greater than 3 mm in largest dimension or located closer than 1.5 mm to the optic nerve or fovea

cT1b - At least one tumour is greater than 3 mm in largest dimension or located closer than 1.5 mm to the optic nerve or fovea. No retinal detachment or subretinal fluid beyond 5 mm from the base of the tumour

cT2

Tumours with vitreous or subretinal seeding or retinal detachment

cT2a - Tumour with subretinal fluid more than 5 mm from the base of any tumour

cT2b - Tumour with vitreous and/or subretinal seeding

cT3

Severe intraocular disease

cT3a - Phthisis or prephthisis bulbi

cT3b - Invasion of  choroid, pars plana, ciliary body, lens, zonules, iris or anterior chamber

cT3c - Raised intraocular pressure with neovascularization and/or buphthalmos

cT3d - Hyphema and/or massive vitreous haemorrhage

cT3e - Aseptic orbital cellulitis

cT4

Extraocular tumour

cT4a - Invasion of optic nerve or orbital tissues

cT4b - Extraocular invasion with proptosis and/or orbital mass

N - regional lymph nodes

N value

Description

cNX

Regional lymph nodes cannot be assessed

cN0

No regional lymph node metastasis

cN1

Regional lymph node metastasis

M - distant metastasis

M value

Description

cM0

No distant metastasis

cM1

Distant Metastasis

cM1a- Single or multiple metastasis to sites other than CNS or brain

cM1b - Metastasis to the CNS including brain


TNM pathological classification

T - primary tumour

pT value

Description

pTX

Primary tumour cannot be assessed

pT0

No evidence of primary tumour

pT1

Tumour confined to eye with no optic nerve or choroidal invasion

pT2

Tumour with intraocular invasion

pT2a - Focal choroidal invasion and pre‐ or intralaminar invasion of the optic nerve head

pT2b - Tumour invasion of stroma of iris and/or trabecular meshwork and/or Schlemm canal

pT3

Tumour with significant local invasion

pT3a - Choroidal invasion larger than 3 mm in diameter or multiple foci of invasion totalling more than 3 mm or any full‐thickness involvement

pT3b - Retrolaminar invasion of optic nerve without invasion of transected end of optic nerve

pT3c - Partial‐thickness involvement of sclera within the inner two‐thirds

pT3d - Full‐thickness invasion into outer third of the sclera and/or invasion into or around emissary channels

pT4

Extraocular extension: Tumour invades optic nerve at transected end, in meningeal space around the optic nerve, full‐thickness invasion of the sclera with invasion of the episclera, adipose tissue, extraocular muscle, bone, conjunctiva, or eyelid.

N - regional lymph nodes

pN value

Description

pNX

Regional lymph nodes cannot be assessed

pN0

No regional lymph node involvement

pN1

Regional lymph node involvement

M - distant metastasis

pM value

Description

cM0

No distant metastasis

pM1

Distant Metastasis

pM1a - Single or multiple metastasis to sites other than CNS

pM1b - Metastasis to CNS parenchyma or cerebrospinal  fluid


Download

Click on the box below to download a PDF version of this staging sheet:

Last edited: 16 January 2026 3:57 pm

  1. Cancer staging guidance sheets
  2. Oral Cavity and mucosal lip (ICD10 C00.3-5, C02-C06)
  3. Malignant melanoma of upper aerodigestive tract (ICD10 C00-06, C09-14, C30-32)
  4. Pharynx (ICD10 C01, C02.4, C05.1-2, C09, C10.0, C10.2-3, C10.9, C11-13)
  5. Salivary glands (ICD10 C00-C14, C15.0, C30-C33, C41.1)
  6. Oesophagus including oesophagogastric junction (ICD10 C15, C16.0)
  7. Gastrointestinal stromal tumours (ICD10 C15-C20, C48.1-2)
  8. Stomach (ICD10 C16 - excluding C16.0)
  9. Small intestine (ICD10 C17)
  10. Appendix (ICD10 C18.1)
  11. Colon and rectum (ICD10 C18-C20)
  12. Anal and perianal skin (ICD10 C21)
  13. Liver (ICD10 C22.0)
  14. Intrahepatic bile ducts (ICD10 C22.1)
  15. Gallbladder (ICD10 C23)
  16. Distal extrahepatic bile duct (ICD10 C24.0)
  17. Perihilar bile ducts (ICD10 C24.0)
  18. Ampulla of vater (ICD10 C24.1)
  19. Pancreas (ICD10 C25)
  20. Nasal cavity and paranasal sinuses (ICD10 C30.0, C31.0, C31.1)
  21. Larynx (ICD10 C32.0, C32.1, C32.2, C10.1)
  22. Lung (ICD10 C34)
  23. Thymus tumours (ICD10 C37.9)
  24. Soft tissues (ICD10 C15-C26, C34-C37 C38.1-3, C47-C49, C51-C53, C58, C60-C68)
  25. Bone (ICD10 C40, C41)
  26. Melanoma of skin (ICD10 C00.0-2, C00.6, C21.2, C43, C51, C60, C63.2)
  27. Merkel cell carcinoma of skin (ICD10 C00, C44, C51, C60, 63.2, C80)
  28. Skin carcinoma of the head and neck (ICD10 C00.0-2, C00.6, C44.0, C44.2-4)
  29. Carcinoma of skin of the eyelid (ICD10 C44.1)
  30. Carcinoma of skin (excluding eyelid, head and neck, perianal, vulva and penis) (ICD10 C44.5-7, C63.2)
  31. Pleural mesothelioma (ICD10 C38.4)
  32. Breast tumours (ICD10 C50)
  33. Vulva (ICD10 C51)
  34. Cervix uteri (ICD10 C53)
  35. Uterine sarcomas
  36. Uterus - endometrium (ICD10 C54.1, C55)
  37. Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
  38. Gestational trophoblastic neoplasms (ICD10 C58)
  39. Penis tumours (ICD10 C60)
  40. Prostate tumours (ICD10 C61.9)
  41. Testis tumours (ICD10 C62)
  42. Kidney tumours (ICD10 C64)
  43. Renal pelvis and ureter tumours (ICD10 C65 & C66)
  44. Urinary bladder tumours (ICD10 C67)
  45. Urethra tumours (ICD10 C68.0, C61.9)
  46. Carcinoma of conjuctiva (ICD10 C69.0)
  47. Melanoma of conjuctiva (ICD10 C69.0)
  48. Retinoblastoma (ICD10 C69.2)
  49. Melanoma of uvea (ICD10 C69.3-4)
  50. Carcinoma of lacrimal gland (ICD10 C69.5)
  51. Sarcoma of orbit (ICD10 C69.6)
  52. Thyroid gland (ICD10 C73.9)
  53. Adrenal cortex (ICD10 C74.0)
  54. Adrenal medulla and extra-adrenal paraganglia (ICD10 C74.1 C75.5)
  55. Parathyroid gland (ICD10 C75.0)
  56. Unknown primary - cervical nodes (ICD10 C77.0)
  57. Mycosis fungoides or sezary syndrome (ICD10 C84.0 and C84.1)
  58. T and B cutaneous lymphoma (ICD10, C82.6, C84.8, C86.6 and other C83-C86 if primary skin excluding C84.0 C84.1)
  59. Rhabdomyosarcoma (CTYA)
  60. Chronic lymphocytic leukaemia
  61. Hepatoblastoma (CTYA)
  62. Hodgkins and non-hodgkins lymphoma (ICD10 C81-88)
  63. Medulloblastoma
  64. Multiple myeloma
  65. Neuroblastoma
  66. Neuroendocrine tumours of the foregut
  67. Neuroendocrine tumours of the midgut and hindgut
  68. Non-hodgkin lymphoma (children)
  69. Wilms tumour of the kidney